pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-137 |
Genomic Coordinates | chr1: 98046070 - 98046171 |
Description | Homo sapiens miR-137 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-137 |
Sequence | 59| UUAUUGCUUAAGAAUACGCGUAG |81 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NCOA3 | ||||||||||||||||||||
Synonyms | ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | ||||||||||||||||||||
Description | nuclear receptor coactivator 3 | ||||||||||||||||||||
Transcript | NM_001174087 | ||||||||||||||||||||
Other Transcripts | NM_001174088 , NM_006534 , NM_181659 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NCOA3 | |||||||||||||||||||||
3'UTR of NCOA3 (miRNA target sites are highlighted) |
>NCOA3|NM_001174087|3'UTR 1 CATCTCTGCACCAGGACCTCTTAAGGAAACCACTGTACAAATGACACTGCACTAGGATTATTGGGAAGGAATCATTGTTC 81 CAGGCATCCATCTTGGAAGAAAGGACCAGCTTTGAGCTCCATCAAGGGTATTTTAAGTGATGTCATTTGAGCAGGACTGG 161 ATTTTAAGCCGAAGGGCAATATCTACGTGTTTTTCCCCCCTCCTTCTGCTGTGTATCATGGTGTTCAAAACAGAAATGTT 241 TTTTGGCATTCCACCTCCTAGGGATATAATTCTGGAGACATGGAGTGTTACTGATCATAAAACTTTTGTGTCACTTTTTT 321 CTGCCTTGCTAGCCAAAATCTCTTAAATACACGTAGGTGGGCCAGAGAACATTGGAAGAATCAAGAGAGATTAGAATATC 401 TGGTTTCTCTAGTTGCAGTATTGGACAAAGAGCATAGTCCCAGCCTTCAGGTGTAGTAGTTCTGTGTTGACCCTTTGTCC 481 AGTGGAATTGGTGATTCTGAATTGTCCTTTACTAATGGTGTTGAGTTGCTCTGTCCCTATTATTTGCCCTAGGCTTTCTC 561 CTAATGAAGGTTTTCATTTGCCATTCATGTCCTGTAATACTTCACCTCCAGGAACTGTCATGGATGTCCAAATGGCTTTG 641 CAGAAAGGAAATGAGATGACAGTATTTAATCGCAGCAGTAGCAAACTTTTCACATGCTAATGTGCAGCTGAGTGCACTTT 721 ATTTAAAAAGAATGGATAAATGCAATATTCTTGAGGTCTTGAGGGAATAGTGAAACACATTCCTGGTTTTTGCCTACACT 801 TACGTGTTAGACAAGAACTATGATTTTTTTTTTTAAAGTACTGGTGTCACCCTTTGCCTATATGGTAGAGCAATAATGCT 881 TTTTAAAAATAAACTTCTGAAAACCCAAGGCCAGGTACTGCATTCTGAATCAGAATCTCGCAGTGTTTCTGTGAATAGAT 961 TTTTTTGTAAATATGACCTTTAAGATATTGTATTATGTAAAATATGTATATACCTTTTTTTGTAGGTCACAACAACTCAT 1041 TTTTACAGAGTTTGTGAAGCTAAATATTTAACATTGTTGATTTCAGTAAGCTGTGTGGTGAGGCTACCAGTGGAAGAGAC 1121 ATCCCTTGACTTTTGTGGCCTGGGGGAGGGGTAGTGCTCCACAGCTTTTCCTTCCCCACCCCCCAGCCTTAGATGCCTCG 1201 CTCTTTTCAATCTCTTAATCTAAATGCTTTTTAAAGAGATTATTTGTTTAGATGTAGGCATTTTAATTTTTTAAAAATTC 1281 CTCTACCAGAACTAAGCACTTTGTTAATTTGGGGGGAAAGAATAGATATGGGGAAATAAACTTAAAAAAAAATCAGGAAT 1361 TTAAAAAAACGAGCAATTTGAAGAGAATCTTTTGGATTTTAAGCAGTCCGAAATAATAGCAATTCATGGGCTGTGTGTGT 1441 GTGTGTATGTGTGTGTGTGTGTGTGTATGTTTAATTATGTTACCTTTTCATCCCCTTTAGGAGCGTTTTCAGATTTTGGT 1521 TGCTAAGACCTGAATCCCATATTGAGATCTCGAGTAGAATCCTTGGTGTGGTTTCTGGTGTCTGCTCAGCTGTCCCCTCA 1601 TTCTACTAATGTGATGCTTTCATTATGTCCCTGTGGATTAGAATAGTGTCAGTTATTTCTTAAGTAACTCAGTACCCAGA 1681 ACAGCCAGTTTTACTGTGATTCAGAGCCACAGTCTAACTGAGCACCTTTTAAACCCCTCCCTCTTCTGCCCCCTACCACT 1761 TTTCTGCTGTTGCCTCTCTTTGACACCTGTTTTAGTCAGTTGGGAGGAAGGGAAAAATCAAGTTTAATTCCCTTTATCTG 1841 GGTTAATTCATTTGGTTCAAATAGTTGACGGAATTGGGTTTCTGAATGTCTGTGAATTTCAGAGGTCTCTGCTAGCCTTG 1921 GTATCATTTTCTAGCAATAACTGAGAGCCAGTTAATTTTAAGAATTTCACACATTTAGCCAATCTTTCTAGATGTCTCTG 2001 AAGGTAAGATCATTTAATATCTTTGATATGCTTACGAGTAAGTGAATCCTGATTATTTCCAGACCCACCACCAGAGTGGA 2081 TCTTATTTTCAAAGCAGTATAGACAATTATGAGTTTGCCCTCTTTCCCCTACCAAGTTCAAAATATATCTAAGAAAGATT 2161 GTAAATCCGAAAACTTCCATTGTAGTGGCCTGTGCTTTTCAGATAGTATACTCTCCTGTTTGGAGACAGAGGAAGAACCA 2241 GGTCAGTCTGTCTCTTTTTCAGCTCAATTGTATCTGACCCTTCTTTAAGTTATGTGTGTGGGGAGAAATAGAATGGTGCT 2321 CTTATCTTTCTTGACTTTAAAAAAATTATTAAAAACAAAAAAAAAATAAATTTTTTTGCAATCCTTTCCTCAGACCTGGC 2401 TCCAGGCTAACTGGAAGGCAGCACTCCCTTTTTTATATAGTAGAAAAATGAAGTTTATTATAAGTTTTTATATTTTCTAC 2481 TTGTTCATTTGGTGCAAACTCAAGATTTCTTTTAATAGGTGCAGTCTTTGAGATAATTTGTTTTTACCTGTATTGCCCTT 2561 TATCTTTTTTAGGTAATTCTTTGTACTCCTGCTGTCTACCTCTCCTCACACCCCAGCACCCCCCATTTTTTCAAACCTTG 2641 GTATCTGTTGGGTGAACAGTATAATCTTTTCATCTGCTTTTAGAATGTGGGATATTTCCAGTACCTACTTTTTTTTTTTT 2721 TTTTTGCTGAATCCAAAGATATATAAATAAAATATATATATTTTATAAAGATCAGAATGATATAAAGGAGATACATGTTT 2801 CTTCCTTTAAAAAATAAACGGAAGTTACATTGTTAATGTTCATATTATGATGCCACTTTTCTAAACTGCATCTGGATTGA 2881 AAGGTGTAAATATCAATAACAGTGCTACTTAGTTATCAGTATTTAATATCTGAGGTGAGTTGGGGGTATCTATATTAGGG 2961 GTAGGGTATTACAGAAGATAATTGGCTTGATGTCCTAGAAGTTCTTTGATCCAGAGGTGGGTGCAGCTGAAAGTAAACAG 3041 AATGGATTGCCAGTTACATGTATGCCTGCCCAGTTCCCTTTTTATTTGCAGAAGCTGTGAGTTTTGTTCACAATTAGGTT 3121 CCTAGGAGCAAAACCTCAAGGATTGATTTATTGTTTTCAACTCCAAGGCACACTGTTAATAAACGAGCAGGGTGTTTTCT 3201 CTCTTCCTTTCTAATATATGGAGTTTCGAAGAATAAAATATGAGAGCAATATTTAAATTCTCAGGAATTGACTTATACTC 3281 TTGAGAATGAATTCAGTTTCAATCAAGTTTACATTATGTTGCTTAAAAAAATAGAAATTATTCTTTATCTTGCAAAGAAT 3361 TGAAACCACATGAAATGACTTATGGGGGATGGTGAGCTGTGACTGCTTTGCTGACCATTTTGGATGTCATTGTAAATAAA 3441 GGTTTCTATTTAAAATTGGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 , T47D , BT474 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
We also identified 3 putative miR-137 binding sites in the SRC3 3-UTR as responsible for the capacity of miR-137 to potently deplete SRC3 expression.
... - Eedunuri VK; Rajapakshe K; Fiskus W; Geng et al., 2015, Molecular endocrinology (Baltimore, Md.). |
Article |
- Eedunuri VK; Rajapakshe K; Fiskus W; Geng et al. - Molecular endocrinology (Baltimore, Md.), 2015
The p160 family of steroid receptor coactivators (SRCs) are pleiotropic transcription factor coactivators and "master regulators" of gene expression that promote cancer cell proliferation, survival, metabolism, migration, invasion, and metastasis. Cancers with high p160 SRC expression exhibit poor clinical outcomes and resistance to therapy, highlighting the SRCs as critical oncogenic drivers and, thus, therapeutic targets. microRNAs are important epigenetic regulators of protein expression. To examine the regulation of p160 SRCs by microRNAs, we used and combined 4 prediction algorithms to identify microRNAs that could target SRC1, SRC2, and SRC3 expression. For validation of these predictions, we assessed p160 SRC protein expression and cell viability after transfection of corresponding microRNA mimetics in breast cancer, uveal melanoma, and prostate cancer (PC) cell lines. Transfection of selected microRNA mimetics into breast cancer, uveal melanoma, and PC cells depleted SRC protein expression levels and exerted potent antiproliferative activity in these cell types. In particular, microRNA-137 (miR-137) depleted expression of SRC1, SRC2, and very potently, SRC3. The latter effect can be attributed to the presence of 3 miR-137 recognition sequences within the SRC3 3'-untranslated region. Using reverse phase protein array analysis, we identified a network of proteins, in addition to SRC3, that were modulated by miR-137 in PC cells. We also found that miR-137 and its host gene are epigenetically silenced in human cancer specimens and cell lines. These results support the development and testing of microRNA-based therapies (in particular based on restoring miR-137 levels) for targeting the oncogenic family of p160 SRCs in cancer.
LinkOut: [PMID: 26066330]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_181659 | 3UTR | CUCUUCCUUUCUAAUAUAUGGAGUUUCGAAGAAUAAAAUAUGAGAGCAAUAUUUAAAUUCUCAGGAAUUGACUUAUACUCUUGAGAAUGAAUUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_181659 | 3UTR | AGCAAUAUUUAAAUUCUCAGGAAUUGACUUAUACUCUUGAGAAUGAAUUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_181659 | 3UTR | AGCAAUAUUUAAAUUCUCAGGAAUUGACUUAUACUCUUGAGAAUGAAUUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000341724.6 | 3UTR | CAAUAUUUAAAUUCUCAGGAAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
140 hsa-miR-137 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT002489 | E2F6 | E2F transcription factor 6 | 4 | 1 | ||||||||
MIRT002490 | CDK6 | cyclin dependent kinase 6 | 4 | 7 | ||||||||
MIRT004004 | NCOA2 | nuclear receptor coactivator 2 | 4 | 1 | ||||||||
MIRT004579 | KDM1A | lysine demethylase 1A | 5 | 3 | ||||||||
MIRT005485 | CDC42 | cell division cycle 42 | 4 | 4 | ||||||||
MIRT005605 | CTBP1 | C-terminal binding protein 1 | 4 | 1 | ||||||||
MIRT005883 | MITF | melanogenesis associated transcription factor | 3 | 1 | ||||||||
MIRT006329 | PTGS2 | prostaglandin-endoperoxide synthase 2 | 2 | 1 | ||||||||
MIRT006957 | ESRRA | estrogen related receptor alpha | 1 | 1 | ||||||||
MIRT007068 | ZNF804A | zinc finger protein 804A | 1 | 1 | ||||||||
MIRT007092 | YBX1 | Y-box binding protein 1 | 3 | 3 | ||||||||
MIRT007252 | CSE1L | chromosome segregation 1 like | 2 | 1 | ||||||||
MIRT007346 | PXN | paxillin | 3 | 1 | ||||||||
MIRT053056 | GLIPR1 | GLI pathogenesis related 1 | 3 | 1 | ||||||||
MIRT053225 | MET | MET proto-oncogene, receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT054547 | FUNDC1 | FUN14 domain containing 1 | 3 | 1 | ||||||||
MIRT054568 | BNIP3L | BCL2 interacting protein 3 like | 3 | 1 | ||||||||
MIRT090615 | PLS1 | plastin 1 | 2 | 2 | ||||||||
MIRT093393 | TMA16 | translation machinery associated 16 homolog | 2 | 2 | ||||||||
MIRT109230 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 6 | ||||||||
MIRT153687 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT170929 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT219251 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT259552 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT271869 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT280623 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 8 | ||||||||
MIRT293284 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT314017 | PAPD7 | poly(A) RNA polymerase D7, non-canonical | 2 | 8 | ||||||||
MIRT374677 | AGO4 | argonaute 4, RISC catalytic component | 2 | 2 | ||||||||
MIRT437385 | FMNL2 | formin like 2 | 1 | 1 | ||||||||
MIRT437406 | RORA | RAR related orphan receptor A | 1 | 1 | ||||||||
MIRT437423 | KIT | KIT proto-oncogene receptor tyrosine kinase | 3 | 1 | ||||||||
MIRT437424 | AKT2 | AKT serine/threonine kinase 2 | 5 | 4 | ||||||||
MIRT437425 | TGFB2 | transforming growth factor beta 2 | 3 | 1 | ||||||||
MIRT437804 | SERPINA3 | serpin family A member 3 | 1 | 1 | ||||||||
MIRT437978 | COX2 | cytochrome c oxidase subunit II | 3 | 1 | ||||||||
MIRT438078 | TRIM13 | tripartite motif containing 13 | 4 | 1 | ||||||||
MIRT438287 | TBX3 | T-box 3 | 1 | 1 | ||||||||
MIRT438288 | KLF4 | Kruppel like factor 4 | 1 | 1 | ||||||||
MIRT438537 | MTDH | metadherin | 2 | 1 | ||||||||
MIRT438757 | Nr1i3 | nuclear receptor subfamily 1, group I, member 3 | 2 | 1 | ||||||||
MIRT442564 | CCDC59 | coiled-coil domain containing 59 | 2 | 2 | ||||||||
MIRT442778 | JAG1 | jagged 1 | 2 | 2 | ||||||||
MIRT444302 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 2 | ||||||||
MIRT446969 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT448824 | FKBP1A | FK506 binding protein 1A | 2 | 4 | ||||||||
MIRT453617 | SNRPE | small nuclear ribonucleoprotein polypeptide E | 2 | 4 | ||||||||
MIRT459217 | MRPS21 | mitochondrial ribosomal protein S21 | 2 | 2 | ||||||||
MIRT463490 | ZC3H11A | zinc finger CCCH-type containing 11A | 2 | 12 | ||||||||
MIRT470084 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT475876 | H3F3C | H3 histone family member 3C | 2 | 10 | ||||||||
MIRT475912 | H3F3B | H3 histone family member 3B | 2 | 8 | ||||||||
MIRT476669 | FUT11 | fucosyltransferase 11 | 2 | 10 | ||||||||
MIRT477346 | EOGT | EGF domain specific O-linked N-acetylglucosamine transferase | 2 | 4 | ||||||||
MIRT477596 | EIF1 | eukaryotic translation initiation factor 1 | 2 | 10 | ||||||||
MIRT478367 | DDI2 | DNA damage inducible 1 homolog 2 | 2 | 2 | ||||||||
MIRT479111 | CNN2 | calponin 2 | 2 | 2 | ||||||||
MIRT482926 | CTPS2 | CTP synthase 2 | 2 | 2 | ||||||||
MIRT485083 | SNRK | SNF related kinase | 2 | 12 | ||||||||
MIRT497120 | NBEAL1 | neurobeachin like 1 | 2 | 2 | ||||||||
MIRT498029 | UBXN4 | UBX domain protein 4 | 2 | 8 | ||||||||
MIRT500603 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 4 | ||||||||
MIRT500927 | SSFA2 | sperm specific antigen 2 | 2 | 8 | ||||||||
MIRT504324 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 6 | ||||||||
MIRT504647 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT506304 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | 2 | 6 | ||||||||
MIRT508007 | BCAT1 | branched chain amino acid transaminase 1 | 2 | 4 | ||||||||
MIRT510538 | XKR7 | XK related 7 | 2 | 2 | ||||||||
MIRT513051 | LYPD6 | LY6/PLAUR domain containing 6 | 2 | 6 | ||||||||
MIRT515223 | COX20 | COX20, cytochrome c oxidase assembly factor | 2 | 8 | ||||||||
MIRT519857 | ZFP62 | ZFP62 zinc finger protein | 2 | 6 | ||||||||
MIRT520508 | TRAM2 | translocation associated membrane protein 2 | 2 | 6 | ||||||||
MIRT522047 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 4 | ||||||||
MIRT524479 | CHRM3 | cholinergic receptor muscarinic 3 | 2 | 4 | ||||||||
MIRT526904 | ZNF772 | zinc finger protein 772 | 2 | 6 | ||||||||
MIRT527862 | SLC39A14 | solute carrier family 39 member 14 | 2 | 2 | ||||||||
MIRT528601 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT532950 | ZNF24 | zinc finger protein 24 | 2 | 4 | ||||||||
MIRT536275 | LMOD2 | leiomodin 2 | 2 | 2 | ||||||||
MIRT537045 | GRAMD4 | GRAM domain containing 4 | 2 | 2 | ||||||||
MIRT537124 | GOLGA3 | golgin A3 | 2 | 4 | ||||||||
MIRT538884 | BTBD1 | BTB domain containing 1 | 2 | 2 | ||||||||
MIRT541457 | AURKA | aurora kinase A | 2 | 2 | ||||||||
MIRT542924 | HOXC8 | homeobox C8 | 2 | 2 | ||||||||
MIRT544580 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | 2 | 4 | ||||||||
MIRT545175 | RFTN2 | raftlin family member 2 | 2 | 2 | ||||||||
MIRT545248 | GTF2E1 | general transcription factor IIE subunit 1 | 2 | 2 | ||||||||
MIRT546473 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT547523 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT548071 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 2 | ||||||||
MIRT548200 | FNIP1 | folliculin interacting protein 1 | 2 | 2 | ||||||||
MIRT551216 | CIDEC | cell death inducing DFFA like effector c | 2 | 2 | ||||||||
MIRT553046 | USP28 | ubiquitin specific peptidase 28 | 2 | 2 | ||||||||
MIRT553875 | SUPT7L | SPT7 like, STAGA complex gamma subunit | 2 | 4 | ||||||||
MIRT554026 | SPCS3 | signal peptidase complex subunit 3 | 2 | 2 | ||||||||
MIRT554153 | SLX4 | SLX4 structure-specific endonuclease subunit | 2 | 2 | ||||||||
MIRT554192 | SLC35E2B | solute carrier family 35 member E2B | 2 | 2 | ||||||||
MIRT554362 | SFXN5 | sideroflexin 5 | 2 | 4 | ||||||||
MIRT555349 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | 2 | 2 | ||||||||
MIRT555822 | PAX9 | paired box 9 | 2 | 2 | ||||||||
MIRT555866 | PAIP1 | poly(A) binding protein interacting protein 1 | 2 | 2 | ||||||||
MIRT555931 | NUP43 | nucleoporin 43 | 2 | 2 | ||||||||
MIRT555993 | NFYB | nuclear transcription factor Y subunit beta | 2 | 2 | ||||||||
MIRT556429 | LONRF3 | LON peptidase N-terminal domain and ring finger 3 | 2 | 2 | ||||||||
MIRT556582 | LHFPL2 | LHFPL tetraspan subfamily member 2 | 2 | 4 | ||||||||
MIRT557220 | HNRNPDL | heterogeneous nuclear ribonucleoprotein D like | 2 | 2 | ||||||||
MIRT558490 | DBN1 | drebrin 1 | 2 | 2 | ||||||||
MIRT560986 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | 2 | 2 | ||||||||
MIRT562291 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT564093 | TLR3 | toll like receptor 3 | 2 | 2 | ||||||||
MIRT565312 | TMEM41A | transmembrane protein 41A | 2 | 2 | ||||||||
MIRT565424 | TEF | TEF, PAR bZIP transcription factor | 2 | 2 | ||||||||
MIRT566946 | LIMCH1 | LIM and calponin homology domains 1 | 2 | 2 | ||||||||
MIRT572369 | ATOX1 | antioxidant 1 copper chaperone | 2 | 2 | ||||||||
MIRT686211 | ZNF267 | zinc finger protein 267 | 2 | 2 | ||||||||
MIRT686935 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT687448 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT710856 | COQ7 | coenzyme Q7, hydroxylase | 2 | 2 | ||||||||
MIRT719484 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT719813 | TXNDC17 | thioredoxin domain containing 17 | 2 | 2 | ||||||||
MIRT720076 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | 2 | 2 | ||||||||
MIRT723920 | ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif 15 | 2 | 2 | ||||||||
MIRT731305 | CUL4A | cullin 4A | 3 | 1 | ||||||||
MIRT732128 | BMP7 | bone morphogenetic protein 7 | 2 | 1 | ||||||||
MIRT732466 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | 3 | 0 | ||||||||
MIRT732962 | TNC | tenascin C | 1 | 0 | ||||||||
MIRT734856 | KDM4A | lysine demethylase 4A | 3 | 0 | ||||||||
MIRT735625 | MEF2A | myocyte enhancer factor 2A | 2 | 0 | ||||||||
MIRT735795 | IL6 | interleukin 6 | 3 | 0 | ||||||||
MIRT736333 | DELE1 | KIAA0141 | 2 | 0 | ||||||||
MIRT736610 | RUNX2 | runt related transcription factor 2 | 3 | 0 | ||||||||
MIRT736830 | NOTCH1 | notch 1 | 3 | 0 | ||||||||
MIRT736888 | KCNA2 | potassium voltage-gated channel subfamily A member 2 | 3 | 0 | ||||||||
MIRT737349 | EGFR | epidermal growth factor receptor | 3 | 0 | ||||||||
MIRT755368 | GLS | glutaminase | 2 | 1 | ||||||||
MIRT755431 | SPHK2 | sphingosine kinase 2 | 3 | 1 | ||||||||
MIRT756119 | USP30 | ubiquitin specific peptidase 30 | 4 | 1 | ||||||||
MIRT756144 | XIAP | X-linked inhibitor of apoptosis | 3 | 1 | ||||||||
MIRT756170 | COL5A1 | collagen type V alpha 1 chain | 3 | 1 | ||||||||
MIRT756171 | FSTL1 | follistatin like 1 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|